2022-2029年全球靜脈注射液市場規模研究和預測，按類型、按溶液成分和區域分析

靜脈注射 （IV） 溶液是通過靜脈直接注入患者血液的無菌液體。它們通常用於醫院、診所和其他醫療環境，為無法口服這些物質的患者提供水合作用、藥物、營養素或其他治療劑。靜脈注射液可以包含水、電解質、糖、維生素和藥物的各種組合，具體取決於患者的需要。它們有不同的濃度和類型，例如等滲、低滲和高滲，這決定了它們對身體體液平衡的影響。推動市場增長的關鍵因素是營養不良患病率的上升，以及為患者提供便利的產品的進步和新創新，預計將在預測期內支援市場增長。

此外，以靜脈溶液為患者主要能源的胃腸道疾病、神經系統疾病和癌症等疾病的流行是市場增長的主要貢獻者之一。根據世界衛生組織的數據，2019年有37萬人死亡，腹瀉是五歲以下兒童死亡的第二大原因。便攜式包裝解決方案的可用性，使患者更容易在舒適的家中而不是在醫院使用點滴，以及產品創新，如預混合解決方案，以提高便利性和減少包裝廢物量是推動市場增長的其他一些因素。例如，2019年6月，專業輸液和藥品的製造商和經銷商Eurolife Healthcare推出了用戶友好和減少傳染病的靜脈注射設備Discport和Lifeport。此外，在預測期內，不斷增長的老年人口預計將為市場創造有利可圖的機會。然而，在2022-2029年的預測期內，缺乏有經驗的醫護人員和靜脈給藥治療的並發症扼殺了市場增長。

全球靜脈注射解決方案市場研究的主要地區包括亞太地區、北美、歐洲、拉丁美洲和世界其他地區。由於主要市場參與者的存在，以及該地區老年人口的增加，北美是全球市場佔有率的主導地區。而亞太地區在預測期內也將表現出最高的增長率，這是因為慢性病發病率上升、各利益相關方之間的合作數量增加以及老齡人口增加等因素將為整個亞太地區的靜脈注射液市場創造有利的增長前景。

該研究的目的是定義近年來不同市場區隔和國家的市場規模，並預測未來幾年的價值。該報告旨在涵蓋參與研究的國家/地區的該行業的定性和定量方面。

該報告還提供了關於關鍵方面的詳細資訊，如驅動因素和挑戰，這將確定市場的未來增長。此外，它還涵蓋了微觀市場的潛在機會，供利益相關者投資，並詳細分析了競爭格局和主要參與者的產品。 .

目錄

第一章：執行摘要

• 市場簡介
• 2019-2029年全球及細分市場的估計和預測
  • 2019-2029年，按地區分類的靜脈注射液市場
  • 2019-2029年靜脈注射液市場，按類型分類
  • 2019-2029年靜脈注射液市場，按溶液成分分類
• 主要趨勢
• 估算方法
• 研究假設

第二章：全球靜脈注射液市場的定義和範圍

• 本研究的目的
• 市場定義和範圍
  • 研究的範圍
  • 行業演變
• 研究涵蓋的年份
• 貨幣兌換率

第三章：全球靜脈注射液市場動態

• 靜脈注射液市場影響分析（2019-2029）。
  • 市場驅動因素
    • 營養不良的流行率上升
    • 產品的進步和新的創新為病人帶來便利
  • 市場挑戰
    • 缺少有經驗的醫療專業人員
    • 靜脈注射療法的並發症
  • 市場機會
    • 老年人口不斷增加

第四章：全球靜脈注射液市場行業分析

• 波特五力模型
  • 供應商的議價能力
  • 買方的議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭性的競爭
• 波特五力模型的未來方法（2019-2029年）
• PEST分析
  • 政治因素
  • 經濟
  • 社會
  • 技術
• 最佳投資機會
• 最佳策略
• 行業專家展望
• 分析師建議和結論

第五章：風險評估：COVID-19的影響

• 評估COVID-19對行業的整體影響
• COVID-19前和COVID-19後的市場情況

第六章：全球靜脈注射液市場，按類型分類

• 市場簡介
• 全球靜脈注射液市場，按類型，性能-潛力分析
• 2019-2029年全球靜脈注射液市場按類型的估計和預測
• 靜脈注射液市場，次級細項分析
  • 全身腸外營養
  • 周邊腸外營養

第7章：全球靜脈注射液市場，按溶液成分分類

• 市場簡介
• 按溶液成分分類的全球靜脈注射液市場，性能-潛力分析
• 2019-2029年全球靜脈注射液市場按溶液成分估計和預測的情況
• 靜脈注射液市場，次級細項分析
  • 鹽水
  • 碳水化合物
  • 維生素和礦物質
  • 其他溶液成分

第八章：全球靜脈注射液市場，區域分析

• 靜脈注射液市場，區域市場簡介
• 北美洲
  • 美國
    • 2019-2029年，類型細分的估計和預測
    • 2019-2029年，溶液成分的細分估計和預測
  • 加拿大
• 歐洲靜脈注射液市場簡介
  • 英國
  • 德國
  • 法國
  • 西班牙
  • 義大利
  • 歐洲其他地區
• 亞太地區靜脈注射液市場簡介
  • 中國
  • 中國
  • 日本
  • 澳大利亞
  • 韓國
  • 亞太其他地區
• 拉丁美洲靜脈注射液市場簡況
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地區
• 世界其他地區

第九章：競爭情報

• 頂級市場戰略
• 公司簡介
  • Amanta Healthcare Ltd.
    • 關鍵資訊
    • 概況
    • 財務（取決於數據的可用性）
    • 產品摘要
    • 近期發展情況
  • Axa Parenterals Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Dickinson and Company
  • Eurolife Healthcare Pvt Ltd.
  • Fresenius Kabi AG
  • Grifols SA
  • Henry Schein Inc.
  • ICU Medical, Inc.

第十章：研究過程

• 研究過程
  • 資料探勘
  • 數據分析
  • 市場評估
  • 驗證
  • 出版
• 研究屬性
• 研究假設

Global Intravenous Solutions Market is valued approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Intravenous (IV) solutions are sterile fluids that are administered directly into a patient's bloodstream through a vein. They are commonly used in hospitals, clinics, and other medical settings to provide hydration, medications, nutrients, or other therapeutic agents to patients who are unable to take these substances orally. IV solutions can contain various combinations of water, electrolytes, sugars, vitamins, and medications, depending on the patient's needs. They come in different concentrations and types, such as isotonic, hypotonic, and hypertonic, which determine their effect on the body's fluid balance. The key factor driving the market growth is rise in prevalence of malnutrition, and advancements and new innovations in the products for patient convenience that anticipated to support the market growth during forecast period.

Moreover, the prevalence of diseases such gastrointestinal disorders, neurological diseases, and cancer, wherein intravenous solutions are the primary energy sources for patients, is one of the main contributors to the market's growth. With 370,000 deaths in 2019, diarrhea is the second most common cause of death in children under the age of five, according to the World Health Organization. Also, the availability of solutions in portable packages, which makes it simpler for patients to use the drips in the comfort of their homes rather than at a hospital, and product innovations such as premixed solutions for improved convenience and to reduce the amount of packaging waste are a few other factors boosting the market's growth. For instance, in June 2019, Eurolife Healthcare, a manufacturer and distributor of specialty infusion and pharmaceuticals, introduced the user-friendly and infectious disease-reduction intravenous IV devices Discport and Lifeport. Additionally, growing geriatric population is anticipated to create the lucrative opportunity for the market during forecast period. However, lack of experienced healthcare professionals and complications of intravenous administration therapy stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Intravenous Solutions Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the presence of key market players, and rise in the geriatric population in the region. Whereas, Asia Pacific is also anticipated to exhibit highest growth rate over the forecast period, owing to factors such as rising prevalence of chronic diseases, increasing number of collaborations between various stakeholders and rising old age population would create lucrative growth prospects for the Intravenous Solutions market across Asia Pacific region.

Major market players included in this report are:

• Amanta Healthcare Ltd.
• Axa Parenterals Ltd.
• B. Braun Melsungen AG
• Baxter International Inc.
• Dickinson and Company
• Eurolife Healthcare Pvt Ltd.
• Fresenius Kabi AG
• Grifols S.A
• Henry Schein Inc.
• ICU Medical, Inc.

Recent Developments in the Market:

• In February 2022, B. Braun Medical has been granted approval by the US FDA to begin manufacturing IV saline solutions at its new plant in Daytona Beach, Florida.

Global Intravenous Solutions Market Report Scope:

• Historical Data: 2019-2020-2021
• Base Year for Estimation: 2021
• Forecast period: 2022-2029
• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered: Type, Solution Composition, Region
• Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Type:

• Total Parenteral Nutrition
• Peripheral Parenteral Nutrition

By Solution Composition:

• Saline
• Carbohydrates
• Vitamins and Minerals
• Other Solution Compositions

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Intravenous Solutions Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Intravenous Solutions Market, by Type, 2019-2029 (USD Billion)
  • 1.2.3. Intravenous Solutions Market, by Solution Composition, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Intravenous Solutions Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Intravenous Solutions Market Dynamics

• 3.1. Intravenous Solutions Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Rise in prevalence of malnutrition
    • 3.1.1.2. Advancements and new innovations in the products for patient convenience
  • 3.1.2. Market Challenges
    • 3.1.2.1. Lack of experienced healthcare professionals
    • 3.1.2.2. Complications of intravenous administration therapy
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Growing geriatric population

Chapter 4. Global Intravenous Solutions Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. Industry Experts Prospective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Intravenous Solutions Market, by Type

• 6.1. Market Snapshot
• 6.2. Global Intravenous Solutions Market by Type, Performance - Potential Analysis
• 6.3. Global Intravenous Solutions Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
• 6.4. Intravenous Solutions Market, Sub Segment Analysis
  • 6.4.1. Total Parenteral Nutrition
  • 6.4.2. Peripheral Parenteral Nutrition

Chapter 7. Global Intravenous Solutions Market, by Solution Composition

• 7.1. Market Snapshot
• 7.2. Global Intravenous Solutions Market by Solution Composition, Performance - Potential Analysis
• 7.3. Global Intravenous Solutions Market Estimates & Forecasts by Solution Composition 2019-2029 (USD Billion)
• 7.4. Intravenous Solutions Market, Sub Segment Analysis
  • 7.4.1. Saline
  • 7.4.2. Carbohydrates
  • 7.4.3. Vitamins and Minerals
  • 7.4.4. Other Solution Compositions

Chapter 8. Global Intravenous Solutions Market, Regional Analysis

• 8.1. Intravenous Solutions Market, Regional Market Snapshot
• 8.2. North America Intravenous Solutions Market
  • 8.2.1. U.S. Intravenous Solutions Market
    • 8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
    • 8.2.1.2. Solution Composition breakdown estimates & forecasts, 2019-2029
  • 8.2.2. Canada Intravenous Solutions Market
• 8.3. Europe Intravenous Solutions Market Snapshot
  • 8.3.1. U.K. Intravenous Solutions Market
  • 8.3.2. Germany Intravenous Solutions Market
  • 8.3.3. France Intravenous Solutions Market
  • 8.3.4. Spain Intravenous Solutions Market
  • 8.3.5. Italy Intravenous Solutions Market
  • 8.3.6. Rest of Europe Intravenous Solutions Market
• 8.4. Asia-Pacific Intravenous Solutions Market Snapshot
  • 8.4.1. China Intravenous Solutions Market
  • 8.4.2. India Intravenous Solutions Market
  • 8.4.3. Japan Intravenous Solutions Market
  • 8.4.4. Australia Intravenous Solutions Market
  • 8.4.5. South Korea Intravenous Solutions Market
  • 8.4.6. Rest of Asia Pacific Intravenous Solutions Market
• 8.5. Latin America Intravenous Solutions Market Snapshot
  • 8.5.1. Brazil Intravenous Solutions Market
  • 8.5.2. Mexico Intravenous Solutions Market
  • 8.5.3. Rest of Latin America Intravenous Solutions Market
• 8.6. Rest of The World Intravenous Solutions Market

Chapter 9. Competitive Intelligence

• 9.1. Top Market Strategies
• 9.2. Company Profiles
  • 9.2.1. Amanta Healthcare Ltd.
    • 9.2.1.1. Key Information
    • 9.2.1.2. Overview
    • 9.2.1.3. Financial (Subject to Data Availability)
    • 9.2.1.4. Product Summary
    • 9.2.1.5. Recent Developments
  • 9.2.2. Axa Parenterals Ltd.
  • 9.2.3. B. Braun Melsungen AG
  • 9.2.4. Baxter International Inc.
  • 9.2.5. Dickinson and Company
  • 9.2.6. Eurolife Healthcare Pvt Ltd.
  • 9.2.7. Fresenius Kabi AG
  • 9.2.8. Grifols S.A
  • 9.2.9. Henry Schein Inc.
  • 9.2.10. ICU Medical, Inc.

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Intravenous Solutions Market, report scope
• TABLE 2. Global Intravenous Solutions Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Intravenous Solutions Market estimates & forecasts by Type 2019-2029 (USD Billion)
• TABLE 4. Global Intravenous Solutions Market estimates & forecasts by Solution Composition 2019-2029 (USD Billion)
• TABLE 5. Global Intravenous Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 6. Global Intravenous Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global Intravenous Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Intravenous Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Intravenous Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Intravenous Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Intravenous Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Intravenous Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Intravenous Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. Global Intravenous Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. U.S. Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 16. U.S. Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 17. U.S. Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 18. Canada Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 19. Canada Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 20. Canada Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 21. UK Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 22. UK Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 23. UK Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 24. Germany Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 25. Germany Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 26. Germany Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 27. France Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 28. France Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 29. France Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 30. Italy Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 31. Italy Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 32. Italy Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 33. Spain Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 34. Spain Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 35. Spain Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 36. RoE Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 37. RoE Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 38. RoE Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 39. China Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 40. China Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 41. China Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 42. India Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 43. India Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 44. India Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 45. Japan Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 46. Japan Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 47. Japan Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 48. South Korea Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 49. South Korea Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 50. South Korea Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 51. Australia Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 52. Australia Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 53. Australia Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 54. RoAPAC Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 55. RoAPAC Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 56. RoAPAC Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 57. Brazil Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 58. Brazil Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 59. Brazil Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 60. Mexico Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 61. Mexico Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 62. Mexico Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 63. RoLA Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 64. RoLA Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 65. RoLA Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 66. Row Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 67. Row Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 68. Row Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 69. List of secondary sources, used in the study of global Intravenous Solutions Market
• TABLE 70. List of primary sources, used in the study of global Intravenous Solutions Market
• TABLE 71. Years considered for the study
• TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Intravenous Solutions Market, research methodology
• FIG 2. Global Intravenous Solutions Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Intravenous Solutions Market, key trends 2021
• FIG 5. Global Intravenous Solutions Market, growth prospects 2022-2029
• FIG 6. Global Intravenous Solutions Market, porters 5 force model
• FIG 7. Global Intravenous Solutions Market, pest analysis
• FIG 8. Global Intravenous Solutions Market, value chain analysis
• FIG 9. Global Intravenous Solutions Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Intravenous Solutions Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Intravenous Solutions Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Intravenous Solutions Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Intravenous Solutions Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Intravenous Solutions Market, regional snapshot 2019 & 2029
• FIG 15. North America Intravenous Solutions Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Intravenous Solutions Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific Intravenous Solutions Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Intravenous Solutions Market 2019 & 2029 (USD Billion)
• FIG 19. Global Intravenous Solutions Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable